Journal article 388 views 17 downloads
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial
Mohammed Fasihul Alam,
Mirella Longo,
David Cohen,
Samantha Groves,
Laith Alrubaiy 
,
Hayley Hutchings ,
Alan Watkins ,
Shaji Sebastain,
John Williams
,
Hayley Hutchings ,
Alan Watkins ,
Shaji Sebastain,
John Williams
BMC Health Services Research, Volume: 23, Issue: 1
Swansea University Authors:
Samantha Groves, Laith Alrubaiy , Hayley Hutchings , Alan Watkins , John Williams
-
PDF | Version of Record
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder
Download (1.35MB)
DOI (Published version): 10.1186/s12913-023-09233-w
Abstract
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial
| Published in: | BMC Health Services Research |
|---|---|
| ISSN: | 1472-6963 |
| Published: |
Springer Science and Business Media LLC
2023
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa62906 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| first_indexed |
2023-03-10T12:27:55Z |
|---|---|
| last_indexed |
2023-04-19T03:23:50Z |
| id |
cronfa62906 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2023-04-18T12:10:31.3118818</datestamp><bib-version>v2</bib-version><id>62906</id><entry>2023-03-10</entry><title>Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial</title><swanseaauthors><author><sid>eb642e3823a000ee7550db9c062c2cdb</sid><ORCID/><firstname>Samantha</firstname><surname>Groves</surname><name>Samantha Groves</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>62b59abd526b328bbb125dfaa9bdcd6d</sid><ORCID>0000-0002-6340-8244</ORCID><firstname>Laith</firstname><surname>Alrubaiy</surname><name>Laith Alrubaiy</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>bdf5d5f154d339dd92bb25884b7c3652</sid><ORCID>0000-0003-4155-1741</ORCID><firstname>Hayley</firstname><surname>Hutchings</surname><name>Hayley Hutchings</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>81fc05c9333d9df41b041157437bcc2f</sid><ORCID>0000-0003-3804-1943</ORCID><firstname>Alan</firstname><surname>Watkins</surname><name>Alan Watkins</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>911a5c03419acf47eab0844e2cd5ab7f</sid><firstname>John</firstname><surname>Williams</surname><name>John Williams</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2023-03-10</date><deptcode>HHE</deptcode><abstract/><type>Journal Article</type><journal>BMC Health Services Research</journal><volume>23</volume><journalNumber>1</journalNumber><paginationStart/><paginationEnd/><publisher>Springer Science and Business Media LLC</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>1472-6963</issnElectronic><keywords/><publishedDay>8</publishedDay><publishedMonth>3</publishedMonth><publishedYear>2023</publishedYear><publishedDate>2023-03-08</publishedDate><doi>10.1186/s12913-023-09233-w</doi><url>http://dx.doi.org/10.1186/s12913-023-09233-w</url><notes/><college>COLLEGE NANME</college><department>Swansea Centre for Health Economics</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HHE</DepartmentCode><institution>Swansea University</institution><apcterm>Other</apcterm><funders>Open Access funding provided by the Qatar National Library. The CONSTRUCT
trial was funded by the NIHR Health Technology Assessment programme
(project no. 06/78/03).</funders><projectreference/><lastEdited>2023-04-18T12:10:31.3118818</lastEdited><Created>2023-03-10T12:18:44.0621936</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Mohammed Fasihul</firstname><surname>Alam</surname><order>1</order></author><author><firstname>Mirella</firstname><surname>Longo</surname><order>2</order></author><author><firstname>David</firstname><surname>Cohen</surname><order>3</order></author><author><firstname>Samantha</firstname><surname>Groves</surname><orcid/><order>4</order></author><author><firstname>Laith</firstname><surname>Alrubaiy</surname><orcid>0000-0002-6340-8244</orcid><order>5</order></author><author><firstname>Hayley</firstname><surname>Hutchings</surname><orcid>0000-0003-4155-1741</orcid><order>6</order></author><author><firstname>Alan</firstname><surname>Watkins</surname><orcid>0000-0003-3804-1943</orcid><order>7</order></author><author><firstname>Shaji</firstname><surname>Sebastain</surname><order>8</order></author><author><firstname>John</firstname><surname>Williams</surname><order>9</order></author></authors><documents><document><filename>62906__26807__7b622e20281b4be184ac1a593ced545e.pdf</filename><originalFilename>Alam_et_al-2023-BMC_Health_Services_Research.pdf</originalFilename><uploaded>2023-03-10T12:27:30.9821198</uploaded><type>Output</type><contentLength>1418039</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
| spelling |
2023-04-18T12:10:31.3118818 v2 62906 2023-03-10 Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial eb642e3823a000ee7550db9c062c2cdb Samantha Groves Samantha Groves true false 62b59abd526b328bbb125dfaa9bdcd6d 0000-0002-6340-8244 Laith Alrubaiy Laith Alrubaiy true false bdf5d5f154d339dd92bb25884b7c3652 0000-0003-4155-1741 Hayley Hutchings Hayley Hutchings true false 81fc05c9333d9df41b041157437bcc2f 0000-0003-3804-1943 Alan Watkins Alan Watkins true false 911a5c03419acf47eab0844e2cd5ab7f John Williams John Williams true false 2023-03-10 HHE Journal Article BMC Health Services Research 23 1 Springer Science and Business Media LLC 1472-6963 8 3 2023 2023-03-08 10.1186/s12913-023-09233-w http://dx.doi.org/10.1186/s12913-023-09233-w COLLEGE NANME Swansea Centre for Health Economics COLLEGE CODE HHE Swansea University Other Open Access funding provided by the Qatar National Library. The CONSTRUCT trial was funded by the NIHR Health Technology Assessment programme (project no. 06/78/03). 2023-04-18T12:10:31.3118818 2023-03-10T12:18:44.0621936 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Mohammed Fasihul Alam 1 Mirella Longo 2 David Cohen 3 Samantha Groves 4 Laith Alrubaiy 0000-0002-6340-8244 5 Hayley Hutchings 0000-0003-4155-1741 6 Alan Watkins 0000-0003-3804-1943 7 Shaji Sebastain 8 John Williams 9 62906__26807__7b622e20281b4be184ac1a593ced545e.pdf Alam_et_al-2023-BMC_Health_Services_Research.pdf 2023-03-10T12:27:30.9821198 Output 1418039 application/pdf Version of Record true This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder true eng http://creativecommons.org/licenses/by/4.0/ |
| title |
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial |
| spellingShingle |
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial Samantha Groves Laith Alrubaiy Hayley Hutchings Alan Watkins John Williams |
| title_short |
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial |
| title_full |
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial |
| title_fullStr |
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial |
| title_full_unstemmed |
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial |
| title_sort |
Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial |
| author_id_str_mv |
eb642e3823a000ee7550db9c062c2cdb 62b59abd526b328bbb125dfaa9bdcd6d bdf5d5f154d339dd92bb25884b7c3652 81fc05c9333d9df41b041157437bcc2f 911a5c03419acf47eab0844e2cd5ab7f |
| author_id_fullname_str_mv |
eb642e3823a000ee7550db9c062c2cdb_***_Samantha Groves 62b59abd526b328bbb125dfaa9bdcd6d_***_Laith Alrubaiy bdf5d5f154d339dd92bb25884b7c3652_***_Hayley Hutchings 81fc05c9333d9df41b041157437bcc2f_***_Alan Watkins 911a5c03419acf47eab0844e2cd5ab7f_***_John Williams |
| author |
Samantha Groves Laith Alrubaiy Hayley Hutchings Alan Watkins John Williams |
| author2 |
Mohammed Fasihul Alam Mirella Longo David Cohen Samantha Groves Laith Alrubaiy Hayley Hutchings Alan Watkins Shaji Sebastain John Williams |
| format |
Journal article |
| container_title |
BMC Health Services Research |
| container_volume |
23 |
| container_issue |
1 |
| publishDate |
2023 |
| institution |
Swansea University |
| issn |
1472-6963 |
| doi_str_mv |
10.1186/s12913-023-09233-w |
| publisher |
Springer Science and Business Media LLC |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| url |
http://dx.doi.org/10.1186/s12913-023-09233-w |
| document_store_str |
1 |
| active_str |
0 |
| published_date |
2023-03-08T04:23:18Z |
| _version_ |
1763663935554191360 |
| score |
10.998093 |